Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP

Last updated on 2022-08-29 History
Report ID 158792
Drug Identification Number 02439409
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Common or Proper name Ropivacaine Hydrochloride Injection, USP
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) ROPIVACAINE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration EPIDURAL EPIDURAL
Packaging size 20mL
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-06-01
Estimated end date 2022-08-26
Actual end date 2022-08-26
Shortage status Resolved
Updated date 2022-08-29
Company comments Effective June 1, 2022 until Aug 26, 2022 we will be encountering a supply interruption with substitution available using our 10 mg/mL 10mL Ampoule.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2022-08-29 French Compare
v12 2022-08-29 English Compare
v11 2022-08-04 French Compare
v10 2022-08-04 English Compare
v9 2022-07-15 French Compare
v8 2022-07-15 English Compare
v7 2022-06-02 English Compare
v6 2022-05-24 French Compare
v5 2022-05-24 English Compare
v4 2022-05-02 French Compare
v3 2022-05-02 English Compare
v2 2022-04-13 French Compare
v1 2022-04-13 English Compare

Showing 1 to 13 of 13